Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Analyst Comment

NeoDynamics receives new order from large hospital in Germany

By Claus ThestrupCEO, Sweden
NeoDynamics

NeoDynamics receives new order from large hospital in Germany.

Order momentum starts to build-up in Europe and NeoDynamics clearly shows the Pro's with the NeoNavia system in breast biopsies and especially the Flexipulse needle.

CEO Anna Eriksrud commented on the order “We are very pleased to announce yet another order for FlexiPulse needles from Germany. Western Rhineland-Palatinate Hospital is among the top 100 rated and distinguished hospitals in Germany and it serves as academic training hospital for the University of Mains. It has a large interdisciplinary sonography department performing all kinds of biopsies. This order clearly demonstrates the commercial viability of our innovative pulse technology and its increasing acceptance by leading practitioners” says Anna Eriksrud, CEO."

Read more: https://www.neodynamics.com/en-gb/press-releases/article/868e3c84-b292-4707-a5f1-6225cd23aee0/neodynamics-receives-new-order-from-large-hospital-in-germany

Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a Digital IR/Corporate Visibility subscription agreement. Claus Thestrup 8:20 AM 19-10-2023.

Login required

This content is only available for logged in users

Create account

NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.